What market crash? These 3 growth stocks have bounced back hard

Paul Summers highlights three growth stocks that have rebounded strongly from March’s market turmoil.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Global indices have recovered some of their value over the last two weeks. But they are still far below where they were when the coronavirus crisis kicked off. 

By sharp contrast, the valuations of some UK companies have bounced to such an extent that March appears as a mere blip on their respective charts. 

Here are three examples that caught my eye.

Pets at Home

Due to “exceptional levels of demand” from pet owners over the last few weeks, retailer Pets at Home (LSE: PETS) has outperformed. Underlying pre-tax profit for the full year is expected to come in “slightly above the top end of the range of current market expectations.” As such, it’s probably no surprise its share price has galloped back to where it was only a few weeks ago. 

Can this positive momentum continue? It’s a tricky one. Having already closed its grooming salons, Pets now expects lower revenue from its vet practices and stores as people only make a trip if absolutely necessary.

Given the company has reported customers “pulling forward purchases,” you have to consider the possibility many owners have already stockpiled enough food for their furry friends should the lockdown be extended.

With no guidance for the next financial year issued, it’s understandable if prospective investors are still reluctant to buy. Nevertheless, the defensive nature of its industry surely makes Pets a far safer bet than other stocks in the FTSE 250

CMC Markets

Online trading provider CMC Markets (LSE: CMCX) is another firm that’s seen its share price recover. Actually, that’s something of an understatement. It’s now higher than before the coronavirus pandemic struck. 

This all feels very logical, given CMC benefits from periods of market volatility. Indeed, recent numbers suggest business is booming. More clients are signing up to use its platform (or logging back in). So the small-cap now expects full-year trading revenue from its main CFD business to be around £214m. This is almost double what it generated in FY19.

Markets are likely to remain jittery for the foreseeable future. But I think those buying now could still make decent gains. Having said it would retain its policy of paying out 50% of post-tax profit to its shareholders, CMC looks a relatively safe bet for income investors too.

Bioventix

Last, but not least, we have antibody developer and supplier Bioventix (LSE: BVXP). While unrelated to the current crisis, last week’s set of interim results helped explain why its share price has now returned to levels seen in February. 

Revenue and pre-tax profit jumped 21% and 31% respectively over the six months to the end of December. In addition to this, Bioventix saw fit to raise its interim dividend by a cracking 20%, to 36p per share.

The near-term outlook was also reassuring. A reduction in some diagnostic testing might impact earnings. But Bioventix expects to continue supplying antibodies to customers in countries affected by Covid-19. This makes sense given that healthcare services have now been prioritised.

The only slight concern for me is the company’s small workforce (16 people). This could become stretched if government guidelines on how companies should operate are modified. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has recommended Bioventix. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

What’s going on with the Direct Line share price?

The Direct Line share price is surging on the back of a preliminary agreement that will see the business join…

Read more »

Investing Articles

£20k in a Stocks & Shares ISA? Consider targeting a £3,121 monthly passive income like this

Looking to build a large passive income for retirement? Royston Wild show how a diversified ISA portfolio could build long-term…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Up 26% this week! Could this FTSE 250 share soar over the next year?

There could be a lot of potential in the mid-cap stocks of the FTSE 250. After a major City bank…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Can anything stop this FTSE 100 growth machine?

Even the pandemic wasn’t able to halt the progress of FTSE 100 events company Informa. But is the stock still…

Read more »

Investing Articles

Will the Rolls-Royce share price hit £6 before the New Year?

At 599.8p, the Rolls-Royce share price has come within a whisper of £6. It’s never been so high, but could…

Read more »

Smartly dressed middle-aged black gentleman working at his desk
Investing Articles

2 REITs I’m considering buying to target a long-term passive income!

REITs can be great sources of passive income over the long term. Here are a couple from the FTSE 100…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

I’m preparing for a stock market crash in 2025

Our writer explains why he's acting 'as if' there will be a stock market crash in 2025, not spending time…

Read more »

Investing Articles

Starting a Stocks and Shares ISA in 2025 could make me a millionaire. Here’s how!

Christopher Ruane outlines a couple of steps he plans to take in the coming year to boost his long-term Stocks…

Read more »